Table 1.

Characteristics of 395 ovarian cancer patients, by survival status, RPCI

CharacteristicAlive (n = 95) n (%)Dead (n = 300) n (%)Crude HR (95% CI)*
Age at diagnosis (y)
    Mean (SD)47.5 (14.1)58.3 (12.3)1.04 (1.03-1.04)
    <4027 (28.4)22 (7.3)Reference
    40-4928 (29.5)52 (17.3)1.75 (1.06-2.87)
    50-5923 (24.2)85 (28.3)2.92 (1.82-4.68)
    ≥6017 (17.9)141 (47.0)3.93 (2.49-6.18)
FIGO stage
    I44 (46.3)39 (13.2)Reference
    II17 (17.9)22 (7.4)1.19 (0.71-2.02)
    III30 (31.6)180 (60.8)3.38 (2.38-4.79)
    IV4 (4.2)55 (18.6)4.36 (2.88-6.61)
Tumor grade
    1: Well differentiated33 (36.3)32 (11.1)Reference
    2: Moderately differentiated21 (23.1)79 (27.5)2.45 (1.62-3.70)
    3: Poorly differentiated36 (39.6)166 (57.8)2.93 (2.00-4.30)
    4: Undifferentiated1 (1.1)10 (3.5)3.72 (1.83-7.58)
Tumor histology
    Serous45 (47.4)225 (75.0)Reference
    Mucinous17 (17.9)17 (5.7)0.39 (0.27-0.64)
    Endometrioid24 (25.3)30 (10.0)0.45 (0.31-0.67)
    Clear cell8 (8.4)20 (6.7)0.73 (0.46-1.16)
    Unknown1 (1.1)8 (2.7)1.01 (0.50-20.5)
Received platinum-based chemotherapy70 (73.7)268 (89.3)1.97 (1.36-2.86)
History of diabetes3 (3.3)25 (8.6)1.61 (1.07-2.44)
History of hypertension19 (20.9)64 (22.0)1.00 (0.76-1.32)
History of thyroid disorder3 (3.3)17 (5.8)1.10 (0.67-1.79)
History of arthritis10 (11.0)42 (14.4)0.96 (0.69-1.33)
History of GERD1 (1.1)7 (2.4)2.30 (1.08-4.88)
  • * Computed using Cox proportional hazard model.